Immunohistochemical study of bcl-2, p53 and Ki-67 expressions in collecting duct carcinoma of the kidney: Five cases and review of the literature on bcl-2, p53 and Ki-67 expressions in renal cell carcinoma and transitional cell carcinoma

Urologia Internationalis

Volumn 69, Issue 1, 2002, Pages 57-62

  Suzuki, Kazumi ^a   Tokue, Akihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

bcl 2; Collecting duct carcinoma; Ki 67 antigen; p53

Indexed keywords

KI 67 ANTIGEN; PARAFFIN; PROTEIN ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE SECTION; BIOSYNTHESIS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; REVIEW; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, RENAL CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY NEOPLASMS; KIDNEY TUBULES, COLLECTING; MALE; MIDDLE AGE; PROTEIN P53; PROTO-ONCOGENE PROTEINS C-BCL-2; HUMANS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035996246     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064362     Document Type: Article

References (52)

1. Bellini duct carcinoma: Further evidence for this rare variant of renal cell carcinoma
2. Retrospective evaluation of c-erbB-2oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney
3. Collecting duct carcinoma of the kidney
4. Papillary renal cell carcinoma: A clinical, radiologic, and pathologic study of 34 cases
5. Collecting duct carcinoma of the kidney
6. Collecting duct carcinoma of the kidney: A case report and review of the literature
7. Collecting duct carcinoma of the kidney
8. Low-grade collecting duct carcinoma of the kidney: Report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin
9. Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-mychave no independent prognostic value in renal adenocarcinoma
10. Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasm
11. Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma
12. Immunohistochemical analysis of bcl-2 protein expression in renal cell carcinoma
13. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma
14. Tumor suppressor gene allelic loss in human renal cancers
15. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-mycto immortalize pre-B cells
16. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium
17. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder
18. Relationship of p53 and bcl-2 to prognosis in muscle invasive transitional cell carcinoma of the bladder
19. Expression of bcl-2 and bcl-x in bladder cancer
20. 1 bladder cancers
21. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder
22. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer
23. Immunohistochemical evaluation of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 expression during bacillus Calmette-Guérin (BCG) intravesical instillation therapy for superficial bladder cancers
24. Expression of bcl-2 oncoprotein in renal cell tumors
25. Expression of Bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma
26. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53
27. The role of bcl-2, p53 and Ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma
28. Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas
29. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis
30. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas
31. Prognostic factors in renal-cell carcinoma: Immunohistochemical detection of p53 protein versus clinico-pathological parameters
32. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type
33. Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma
34. Nuclear p53 overexpression in bladder, prostate, and renal carcinoma
35. Association of immunohistochemical staining for p53 with metastasis progression and poor survival in patients with renal cell carcinoma
36. p53 mutations and other prognostic factors of renal cell carcinoma
37. Immunohistochemical determination of p53 overexpression
38. Accumulation of nuclear p53 and tumor progression in bladder cancer
39. p53 and Rb immunostaining in locally advanced bladder cancer: Relation to prognostic variables and predictive value for the local response to radical radiotherapy
40. Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: Correlation to clinical outcome
41. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value
42. Serum anti-p53 antibodies and p53 protein status in the sera and tumors from bladder cancer patients
43. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with DNA ploidy
44. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC
45. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: Correlation with Ki67 index
46. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy
47. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression
48. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas
49. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67
50. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
51. c-myccopy number gains in bladder cancer detected by fluorescence in situ hybridization